Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
173 hedge funds and large institutions have $881M invested in Spectrum Pharmaceuticals Inc in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 76 increasing their positions, 38 reducing their positions, and 22 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 38
16% more capital invested
Capital invested by funds: $757M → $881M (+$123M)
2% less funds holding
Funds holding: 176 → 173 (-3)
14% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 22
56% less call options, than puts
Call options by funds: $727K | Put options by funds: $1.66M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$9.11M |
| 2 |
Renaissance Technologies
New York
|
+$7.42M |
| 3 |
SCM
Sio Capital Management
New York
|
+$5.93M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$5.9M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$5.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$26M |
| 2 |
O
OrbiMed
New York
|
-$19.8M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$13.6M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.72M |
SPPI Hedge Fund Activity: Q1 2019 in Review
173 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q1 2019, worth a combined $881M — up 16% from $757M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of SPPI and 19 opened new positions — a net loss of 3 holders — while 38 trimmed existing stakes and 76 added.
The largest buyer was Millennium Management, adding an estimated $9.11M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $26M sold.
- 173 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q1 2019, down from 176 in Q4 2018.
- Funds reported $881M of Spectrum Pharmaceuticals Inc stock for Q1 2019, up 16% quarter-over-quarter.
- 19 funds opened new Spectrum Pharmaceuticals Inc positions in Q1 2019 and 22 closed out, a net change of -3 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q1 2019 was Millennium Management, an estimated $9.11M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q1 2019 was Consonance Capital Management, an estimated $26M sold.
Based on aggregated 13F filings for Q1 2019.